Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.395 USD | -2.77% | +7.32% | -12.18% |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.18% | 186M | |
+43.97% | 56.65B | |
-6.64% | 39.44B | |
+38.65% | 39.03B | |
-11.17% | 26.86B | |
+13.46% | 26.75B | |
-21.82% | 19.03B | |
+1.71% | 12.28B | |
+24.86% | 12.26B | |
+27.71% | 12.04B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc. - Shareholder/Analyst Call